Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers. Innovation has the potential to improve preclinical research by reducing reliance on animal testing through New Approach Methodologies (NAMs) such as organoids and predictive modeling, enabling new directions and scale in advanced biomedical studies. Partnership underscores Bio-Techne's commitment [...]

BICO Group AB today announces the appointment of Ewa Linsäter as Chief Financial Officer. She will succeed Jacob Thordenberg, who has decided to leave BICO to pursue his career outside the Group. Ewa Linsäter has 15+ years’ experience of working as a Chief Financial Officer (CFO) whereof the last six years at Elos Medtech. Prior [...]

WALNUT CREEK, Calif. -- TraxStar, a leader in laboratory management software for discrete manufacturing, announces the release of SynQ, a powerful new platform that enables organizations to design custom resources and workflows with virtually no limitations. Built for teams that need more than traditional LIMS can offer, SynQ empowers users to create digital workflows without [...]

Pioneering the next era of discovery by integrating AI algorithms with robotics execution to reinvent how new medicines are designed. SAN FRANCISCO -- Medra, the company developing the first platform for Physical AI Scientists, today announced a $52 million Series A financing led by Human Capital, with participation from existing investors Lux Capital, Neo, and [...]

Parse’s GigaLab to provide industry leading, large-scale, single cell services to support Tahoe’s development of foundational biological datasets SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Tahoe Therapeutics has selected Parse’s GigaLab to generate data for its upcoming 300M cell project. Tahoe will use its proprietary Mosaic technology to [...]

New priority program opens up exclusive opportunities for collaborative research on transformative clinical potential of DNAe's flagship tests and to gain preview of breakthrough LiDia-SEQ™ platform LONDON and CARLSBAD, Calif. -- DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of [...]

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year 2025 financial outlook RADNOR, Pa. -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announced today that it has appointed Jon [...]

Mike Hampton, Chief Commercial Officer, Sapio Sciences Sapio Sciences, the science-awareTM AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute's ambitious lab transformation program. The Sanger Institute will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale [...]

ETTLINGEN, Germany -- Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: AVANCE NEO 1 GHz system with a range of liquids and solids NMR probes for biological and material science applications In the summer, École Normale Supérieure (ENS-PSL) in Paris, France ordered [...]

Simoa® HD-X Receives MFDS Class I IVD Import Clearance, Enabling the First Clinical Introduction of Simoa® Technology in Korea Seoul, Republic of Korea – Quanterix Corporation (NASDAQ: QTRX), a U.S.-based biotechnology company specializing in ultrasensitive biomarker detection, and its clinical diagnostics brand Lucent Diagnostics, together with Emocog Inc. (Co-CEOs Jun-Young Lee and Yoo-Hun Noh), a digital [...]